Collaborations, Competitor News, Data Partnership, RWE Study

Foundation Medicine and Collaborators to Share More Than 20 Abstracts Featuring New Data at the 2022 American Society of Clinical Oncology Annual Meeting Highlighting How Molecular Profiling is Helping to Shape the Future of Personalized Cancer Care

Key data reinforce the utility of Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to support treatment planning, and demonstrate the value of real-world genomic data to facilitate equitable research May 26, 2022 05:05 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer,…

Competitor News, Oncology

Global Oncology Trends 2022

Outlook to 2026 Institute Report May 26, 2022 Web Summary Oncology is the leading therapy area for innovation – in terms of the level of clinical trial activity, number of companies investing in therapeutics, size of the pipeline of therapies in clinical development, novel active substances being launched, and the…

Partner and Collaborator News

Rubicon Enters Strategic Partnership with Palantir Technologies

Leading digital marketplace for waste and recycling expands data, analytics, and reporting capabilities with new partnership May 26, 2022 08:45 ET | Source: Rubicon Technologies, LLC Lexington, Kentucky, May 26, 2022 (GLOBE NEWSWIRE) — Rubicon Technologies, LLC (“Rubicon” or the “Company”), a digital marketplace for waste and recycling and provider of innovative software-based solutions…

Competitor News, Product Updates

Prognos Health Enhances HCP Precision Marketing Suite with Planning Engine to Accelerate RWD Insights and Improve Health Outcomes

Pharma marketers now have easy access to identify patient populations with precision and plan before they acquire the right RWD to integrate into their HCP omnichannel disease awareness campaigns. May 26, 2022 07:07 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Real world data marketplace and analytics platform leader, Prognos Health, today announced…

AI, Competitor News, Ethics, Europe, Government/Regulatory, International

Bindmans advises medConfidential as NHS Trusts share patient data with Sensyne Health

Over recent years, multiple NHS trusts have signed a partnership with Sensyne Health Plc, a company which uses artificial intelligence to analyse medical data. These contracts involved the Trusts providing NHS patient data in return for shares. As of January 2022, Sensyne reported that it had a database of 48.3…

HR, Partner and Collaborator News

Internationally renowned cancer researcher joins cancer center’s leadership team

(SACRAMENTO) Xiao-Jing Wang joined the UC Davis Comprehensive Cancer Center today, May 25, 2022, as chief science officer. She will also be associate director for basic science, the leadership role previously held by  Luis Carvajal-Carmona who was recently appointed the cancer center’s inaugural chief diversity officer and director of the new Center for Advancing Cancer…

China, Industry News, International

Real-World Evidence Is Becoming a Pivotal Component in Chinese Healthcare

May 25, 2022 Bruce Liu, Justinian Liu, Selene Peng, Wolfgang Liang Its use enables key processes such as early access, regulatory approval, and reimbursement listing. Real world evidence (RWE) is playing an increasingly important role in China, ranging from early access and regulatory approval to reimbursement listing and commercialization.This information is obtained from real world…

Partner and Collaborator News

Palantir Announces Global Enterprise Deal with Stellantis

May 25, 2022 01:00 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR, “Palantir”) today announced a partnership with one of the world’s leading automakers and mobility providers Stellantis N.V. Stellantis will deploy Palantir’s Foundry operating system across the company’s brands, business functions and plant locations to accelerate its digital transformation…